{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:53:59Z","timestamp":1793483639300,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00483"],"award-info":[{"award-number":["CB16\/11\/00483"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01469"],"award-info":[{"award-number":["PI18\/01469"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-113098RB-I00"],"award-info":[{"award-number":["PID2020-113098RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007680","name":"Universidad P\u00fablica de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["848109"],"award-info":[{"award-number":["848109"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.metabol.2022.155348","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T16:05:09Z","timestamp":1669046709000},"page":"155348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Revisiting skeletal myopathy and exercise training in heart failure: Emerging role of myokines"],"prefix":"10.1016","volume":"138","author":[{"given":"Robinson","family":"Ram\u00edrez-V\u00e9lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Garc\u00eda-Hermoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo Latasa","family":"Am\u00e9zqueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155348_bb0005","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jacc.2019.01.072","article-title":"Exercise intolerance in patients with heart failure: JACC state-of-the-art review","volume":"73","author":"Del Buono","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0010","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2021.07.014","article-title":"Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review","volume":"78","author":"Pandey","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: mechanisms and therapies","volume":"14","author":"Von Haehling","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11897-020-00468-w","article-title":"Heart failure\u2013induced skeletal muscle wasting","volume":"17","author":"Philippou","year":"2020","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.metabol.2022.155348_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ejhf.1838","article-title":"Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials","volume":"23","author":"von Haehling","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0030","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.jacc.2018.08.2160","article-title":"American College of Cardiology's Nutrition and Lifestyle Committee of the Prevention of Cardiovascular Disease Council. Lifestyle modifications for preventing and treating heart failure","volume":"72","author":"Aggarwal","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0035","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2021.01.030","article-title":"Cardiac rehabilitation for patients with heart failure: JACC expert panel","volume":"77","author":"Bozkurt","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ejhf.2407","article-title":"Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?","volume":"24","author":"Nijholt","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"2\u20133","key":"10.1016\/j.metabol.2022.155348_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1026070911202","article-title":"Searching for the exercise factor: is IL-6 a candidate?","volume":"24","author":"Pedersen","year":"2003","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.metabol.2022.155348_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13766","article-title":"Factors mediating exercise-induced organ crosstalk","volume":"234","author":"Sabaratnam","year":"2022","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.metabol.2022.155348_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-022-00641-2","article-title":"Exerkines in health, resilience and disease","author":"Chow","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2022.155348_bb0060","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle\u2013organ crosstalk: the emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2022.155348_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11897-018-0408-6","article-title":"Impaired exercise tolerance in heart failure: role of skeletal muscle morphology and function","volume":"15","author":"Tucker","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.metabol.2022.155348_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003027","article-title":"Skeletal muscle alterations are exacerbated in heart failure with reduced compared with preserved ejection fraction","volume":"9","author":"Seiler","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0075","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2009.11.086","article-title":"Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors","volume":"55","author":"Esposito","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-016-9593-0","article-title":"Skeletal muscle inflammation and atrophy in heart failure","volume":"22","author":"Lavine","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.metabol.2022.155348_bb0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.114.001825","article-title":"Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction","volume":"8","author":"Dhakal","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fcvm.2020.00079","article-title":"Abnormalities of skeletal muscle, adipocyte tissue, and lipid metabolism in heart failure: practical therapeutic targets","volume":"7","author":"Takada","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2022.155348_bb0095","doi-asserted-by":"crossref","first-page":"H2988","DOI":"10.1152\/ajpheart.00008.2007","article-title":"Impaired central hemodynamic response and exaggerated vasoconstriction during muscle metaboreflex activation in heart failure patients","volume":"292","author":"Crisafulli","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1113\/expphysiol.2013.074310","article-title":"Pathophysiology of human heart failure: importance of skeletal muscle myopathy and reflexes","volume":"99","author":"Piepoli","year":"2014","journal-title":"Exp Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41569-018-0065-1","article-title":"Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors","volume":"15","author":"Fiuza-Luces","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6644631","article-title":"Myokines and heart failure: challenging role in adverse cardiac remodeling, myopathy, and clinical outcomes","volume":"2021","author":"Berezin","year":"2021","journal-title":"Dis Markers"},{"key":"10.1016\/j.metabol.2022.155348_bb0115","first-page":"1008","article-title":"Heart failure-related skeletal myopathy. Potential involvement of myokines","volume":"74","author":"Latasa Am\u00e9zqueta","year":"2021","journal-title":"Rev Esp Cardiol. (Engl Ed)"},{"issue":"Pt 1","key":"10.1016\/j.metabol.2022.155348_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2000.00237.x","article-title":"Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6","volume":"529","author":"Steensberg","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0125","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1152\/ajpendo.00255.2002","article-title":"IL-6 and TNF-alpha expression in, release from, contracting human skeletal muscle","volume":"283","author":"Steensberg","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2022.155348_bb0130","first-page":"8","article-title":"Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects","volume":"21","author":"Peake","year":"2015","journal-title":"Exerc Immunol Rev"},{"key":"10.1016\/j.metabol.2022.155348_bb0135","article-title":"Inflammatory cytokines, immune cells, and organ interactions in heart failure","author":"Li","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155348_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.662908","article-title":"Deciphering myostatin's regulatory, metabolic, and developmental influence in skeletal diseases","volume":"12","author":"Omosule","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.metabol.2022.155348_bb0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardiores.2007.02.023","article-title":"Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation","volume":"74","author":"McKoy","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2022.155348_bb0155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1741826711402735","article-title":"Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure","volume":"19","author":"Lenk","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/CIRCHEARTFAILURE.120.007198","article-title":"Skeletal muscle function, structure, and metabolism in patients with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction","volume":"13","author":"Bekfani","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0165","doi-asserted-by":"crossref","first-page":"H1463","DOI":"10.1152\/ajpheart.00187.2018","article-title":"Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery","volume":"315","author":"Castillero","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0170","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfq039","article-title":"Myostatin activation in patients with advanced heart failure and after mechanical unloading","volume":"12","author":"George","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.hlc.2017.05.138","article-title":"Absence of myostatin improves cardiac function following myocardial infarction","volume":"27","author":"Lim","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.metabol.2022.155348_bb0180","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ymthe.2019.01.013","article-title":"Systemic blockade of ACVR2B ligands protects myocardium from acute ischemia-reperfusion injury","volume":"27","author":"Magga","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.metabol.2022.155348_bb0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00441-015-2139-2","article-title":"Myostatin induces interstitial fibrosis in the heart via TAK1 and p38","volume":"361","author":"Biesemann","year":"2015","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.metabol.2022.155348_bb0190","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","article-title":"Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure","volume":"121","author":"Heineke","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155348_bb0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155348_bb0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/endrev\/bnab003","article-title":"Progress and challenges in the biology of FNDC5 and irisin","volume":"42","author":"Maak","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2022.155348_bb0205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/CIRCHEARTFAILURE.112.969543","article-title":"Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure","volume":"5","author":"Lecker","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcsm.12006","article-title":"Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines","volume":"6","author":"Matsuo","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.metabol.2022.155348_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10520295.2017.1303194","article-title":"Immunohistochemical localization of irisin in mole rats (Spalax leucodon)","volume":"92","author":"G\u00fcr","year":"2017","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.metabol.2022.155348_bb0220","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","article-title":"Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway","volume":"121","author":"Li","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0225","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jcmm.13360","article-title":"Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy","volume":"22","author":"Liu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2022.155348_bb0230","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fphar.2020.00769","article-title":"Irisin improves myocardial performance and attenuates insulin resistance in spontaneous mutation (Leprdb) mice","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2022.155348_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/FJC.0000000000000608","article-title":"Irisin protects heart against ischemia-reperfusion injury through a SOD2-dependent mitochondria mechanism","volume":"72","author":"Wang","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2022.155348_bb0240","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","article-title":"The exerkine apelin reverses age-associated sarcopenia","volume":"24","author":"Vinel","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2022.155348_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170697","article-title":"Apelin pathway in cardiovascular, kidney, and metabolic diseases: therapeutic role of apelin analogs and apelin receptor agonists","volume":"147","author":"de Oliveira","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2022.155348_bb0250","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"F\u00f6ldes","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2022.155348_bb0255","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1476-5381.2010.00821.x","article-title":"Modulation of the apelin\/APJ system in heart failure and atherosclerosis in man","volume":"160","author":"Pitkin","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2022.155348_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41467-021-27634-5","article-title":"Skeletal muscle derived musclin protects the heart during pathological overload","volume":"13","author":"Szaroszyk","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2022.155348_bb0265","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1042\/CS20171463","article-title":"Non-coding RNAs and exercise: pathophysiological role and clinical application in the cardiovascular system","volume":"132","author":"Gomes","year":"2018","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2022.155348_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.567614","article-title":"Long non-coding RNAs are differentially expressed after different exercise training programs","volume":"11","author":"Bonilauri","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0275","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbrc.2019.11.019","article-title":"Exercise protects the heart against myocardial infarction through upregulation of miR-1192","volume":"521","author":"Wang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2022.155348_bb0280","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/CIRCULATIONAHA.121.056850","article-title":"lncExACT1 and DCHS2 regulate physiological and pathological cardiac growth","volume":"145","author":"Li","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155348_bb0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000500320","article-title":"Myokines: an available biomarker to evaluate cardiac function?","volume":"142","author":"Duan","year":"2019","journal-title":"Cardiology"},{"key":"10.1016\/j.metabol.2022.155348_bb0290","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0295","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/heartasia-2013-010484","article-title":"A meta-analysis of proinflammatory cytokines in chronic heart failure","volume":"6","author":"Liu","year":"2014","journal-title":"Heart Asia"},{"key":"10.1016\/j.metabol.2022.155348_bb0300","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155348_bb0305","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with chronic heart failure","volume":"102","author":"Rauchhaus","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155348_bb0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2019.04.017","article-title":"Predictive value of serum myostatin for the severity and clinical outcome of heart failure","volume":"64","author":"Chen","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.metabol.2022.155348_bb0315","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurjhf\/hfr024","article-title":"Increased plasma myostatin in heart failure","volume":"13","author":"Gruson","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0320","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijcard.2016.06.231","article-title":"Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure","volume":"220","author":"Furihata","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0325","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1139\/cjpp-2018-0736","article-title":"Serum irisin level in myocardial infarction patients with or without heart failure","volume":"97","author":"Abd El-Mottaleb","year":"2019","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2022.155348_bb0330","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1038\/s41598-021-87974-6","article-title":"Prediction of sarcopenia using a battery of circulating biomarkers","volume":"11","author":"Qaisar","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2022.155348_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210320","article-title":"Circulating irisin levels in heart failure with preserved or reduced ejection fraction: a pilot study","volume":"14","author":"Silvestrini","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155348_bb0340","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/jcm9041021","article-title":"Electrical and hormonal biomarkers in cachectic elderly women with chronic heart failure","volume":"9","author":"Sobieszek","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2022.155348_bb0345","first-page":"39","article-title":"Adropin and irisin in patients with cardiac cachexia","volume":"111","author":"Kalkan","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0350","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.12225","article-title":"Exercise and heart failure: an update","volume":"5","author":"Cattadori","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0360","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155348_bb0365","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s12603-021-1665-8","article-title":"International exercise recommendations in older adults (ICFSR): expert consensus guidelines","volume":"25","author":"Izquierdo","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.metabol.2022.155348_bb0370","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2666-7568(21)00079-9","article-title":"Physical activity guidelines for older people: knowledge gaps and future directions","volume":"2","author":"Izquierdo","year":"2021","journal-title":"Lancet Health Longev"},{"key":"10.1016\/j.metabol.2022.155348_bb0375","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.3390\/ijms21103607","article-title":"Physical exercise and myokines: relationships with sarcopenia and cardiovascular complications","volume":"21","author":"Barbalho","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"39","key":"10.1016\/j.metabol.2022.155348_bb0380","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0735-1097(02)01736-9","article-title":"Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure","volume":"2002","author":"Hambrecht","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0385","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0735-1097(03)00848-9","article-title":"Anti-inflammatory effects of exercise train-ing in the skeletal muscle of patients with chronic heart failure","volume":"42","author":"Gielen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardfail.2016.06.007","article-title":"Effects of high-intensity interval exercise training on skeletal myopathy of chronic heart failure","volume":"23","author":"Tzanis","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0395","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fphys.2019.00287","article-title":"Exercise-induced myokines with therapeutic potential for muscle wasting","volume":"10","author":"Piccirillo","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0400","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11033-020-06067-1","article-title":"The role of irisin in multiorgan protection","volume":"48","author":"Ma","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.metabol.2022.155348_bb0405","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.112.115089","article-title":"Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models","volume":"126","author":"Ogura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155348_bb0410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphys.2020.00091","article-title":"Exercise-released myokines in the control of energy metabolism","volume":"11","author":"Laurens","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110869","article-title":"The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men","volume":"133","author":"Bagheri","year":"2020","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.metabol.2022.155348_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121367","article-title":"Irisin in blood increases transiently after single sessions of intense endurance exercise and heavy strength training","volume":"10","author":"Nygaard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155348_bb0425","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/eurjhf\/hfp020","article-title":"Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model","volume":"11","author":"Lenk","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0430","doi-asserted-by":"crossref","first-page":"271","DOI":"10.33549\/physiolres.932997","article-title":"Effect of aerobic training and resistance training on circulating irisin level and their association with change of body composition in overweight\/obese adults: a pilot study","volume":"65","author":"Kim","year":"2016","journal-title":"Physiol Res"},{"key":"10.1016\/j.metabol.2022.155348_bb0435","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0440","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.hfc.2020.02.004","article-title":"Obesity-related heart failure with preserved ejection fraction: pathophysiology, diagnosis, and potential therapies","volume":"16","author":"Harada","year":"2020","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.metabol.2022.155348_bb0445","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2022.155348_bb0450","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.jacc.2016.08.072","article-title":"Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction","volume":"68","author":"Carbone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0455","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ejhf.1304","article-title":"Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"20","author":"Emami","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155348_bb0460","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd.2016.153","article-title":"The ever-expanding myokinome: discovery challenges and therapeutic implications","volume":"15","author":"Whitham","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2022.155348_bb0465","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1113\/JP278761","article-title":"Mimicking exercise: what matters most and where to next?","volume":"599","author":"Hawley","year":"2021","journal-title":"J Physiol"},{"key":"10.1016\/j.metabol.2022.155348_bb0470","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3389\/fphys.2018.01307","article-title":"Physical exercise-induced myokines and muscle-adipose tissue crosstalk: a review of current knowledge and the implications for health and metabolic diseases","volume":"9","author":"Leal","year":"2018","journal-title":"Front Physiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522002268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522002268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:33:23Z","timestamp":1758429203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522002268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":94,"alternative-id":["S0026049522002268"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155348","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting skeletal myopathy and exercise training in heart failure: Emerging role of myokines","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155348"}}